Last updated: June 13, 2019
Sponsor: Kaohsiung Medical University
Overall Status: Active - Recruiting
Phase
4
Condition
Scar Tissue
Treatment
N/AClinical Study ID
NCT03982862
KMUHIRB-F(II)-20180062
Ages 18-60 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patients have visible hypertrophic scars or keloids over three months after trauma orsurgery.
Patients have symptoms of pain, itching or erythema.
Exclusion
Exclusion Criteria:
Patients had either Botulinum toxin type A or Triamcinolone intralesional before inthe same scar
The scar size is larger than 10 cm2
Immunocompromised status
Systemic infection status
Allergic to Botulinum toxin type A or steroids
Study Design
Total Participants: 20
Study Start date:
July 30, 2018
Estimated Completion Date:
June 30, 2019
Study Description
Connect with a study center
Kaohsiung Medical University Hospital
Kaohsiung,
TaiwanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.